News and Resources
Rosemary Gibson, author of “China Rx: Exposing the Risks of America’s Dependence on China for Medicine,” on why Medicare should require hospitals to buy American-made essential generic medications.
Advanced Pharmaceutical Manufacturing Campus in Central Virginia Will Create 186 New Jobs in City of Petersburg
A unique partnership between Civica Rx, Phlow, VCU’s Medicines for All Institute, and AMPAC Fine Chemicals to ensure every American will have access to essential medicines.
Revolutionizing Pharma Manufacturing From The Outside In
Phlow’s Mission to Secure Essential Medicines through U.S. Manufacturing Featured in Outsourced Pharma
Stop Drug Shortages, Start Domestic Supply Chains
How Phlow is revamping the way medicines are made and distributed.
Phlow’s mission to reliably supply affordable, high-quality, essential medicines through U.S.-based advanced manufacturing processes.
Phlow honored with “Inno on Fire” Award for its impact on U.S.-based pharmaceutical manufacturing of essential medicines.
White House officials called the multi-million dollar contract with Virginia-based Phlow Corp. a potential landmark in returning pharmaceutical manufacture from overseas.
Dr. Eric Edwards, CEO of Phlow Corp., joins “Squawk Alley” to discuss manufacturing essential medicines in the U.S.
A new Richmond-based pharmaceutical manufacturing company has received a $354 million federal contract to help build a strategic, national reserve of essential medications and to make active ingredients for more than a dozen medicines used to treat patients with COVID-19.